Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Shares · CUSIP: H0036K147

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Prosight Management, LP

    Shares: 7,195,374.00 · Class: 5.8%

  • Prosight Fund, LP

    Shares: 350,415.00 · Class: 0.3%

  • Prosight Plus Fund, LP

    Shares: 1,586,895.00 · Class: 1.3%

  • Prosight Partners, LLC

    Shares: 7,195,374.00 · Class: 5.8%

  • W. Lawrence Hawkins

    Shares: 7,195,374.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-111601
Form type
SCHEDULE 13G/A
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub